KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cme Group (CME) Invested Capital: 2009-2025

Historic Invested Capital for Cme Group (CME) over the last 17 years, with Sep 2025 value amounting to $28.2 billion.

  • Cme Group's Invested Capital fell 2.68% to $28.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $28.2 billion, marking a year-over-year decrease of 2.68%. This contributed to the annual value of $27.2 billion for FY2024, which is 1.87% up from last year.
  • As of Q3 2025, Cme Group's Invested Capital stood at $28.2 billion, which was up 1.63% from $27.7 billion recorded in Q2 2025.
  • In the past 5 years, Cme Group's Invested Capital registered a high of $29.0 billion during Q3 2024, and its lowest value of $26.6 billion during Q1 2021.
  • In the last 3 years, Cme Group's Invested Capital had a median value of $27.8 billion in 2023 and averaged $27.8 billion.
  • Its Invested Capital has fluctuated over the past 5 years, first climbed by 6.95% in 2021, then fell by 4.45% in 2022.
  • Cme Group's Invested Capital (Quarterly) stood at $28.1 billion in 2021, then fell by 4.45% to $26.9 billion in 2022, then fell by 0.58% to $26.7 billion in 2023, then grew by 1.87% to $27.2 billion in 2024, then decreased by 2.68% to $28.2 billion in 2025.
  • Its Invested Capital stands at $28.2 billion for Q3 2025, versus $27.7 billion for Q2 2025 and $27.0 billion for Q1 2025.